The International Myeloma Foundation Says Positive Recommendation by Regulatory Body Brings Myeloma Patients in Europe Closer to Accessing Latest Treatment

NORTH HOLLYWOOD, Calif.--(BUSINESS WIRE)--The International Myeloma Foundation said Pomalidomide for myeloma could be available to patients in Europe within the next few months. It has been given a positive opinion from the EU's CHMP. Reported by Business Wire 44 minutes ago.